Quarterly report · Q1

Period2023-01-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedNo
Data checks9 of 9 passed
Key figures · 22
MetricValuePeriodScopeSource row
Revenue¥7m2023-01-01 → 2023-03-31StandaloneNet sales
Revenue¥374m2022-01-01 → 2022-12-31StandaloneNet sales (5-year summary)
Operating income−¥172m2023-01-01 → 2023-03-31StandaloneOperating income
Ordinary income−¥167m2023-01-01 → 2023-03-31StandaloneOrdinary income
Ordinary income−¥433m2022-01-01 → 2022-12-31StandaloneOrdinary income loss (5-year summary)
Profit before tax−¥167m2023-01-01 → 2023-03-31StandaloneIncome before income taxes
Net income−¥168m2023-01-01 → 2023-03-31StandaloneProfit loss
Net income−¥474m2022-01-01 → 2022-12-31StandaloneNet income loss (5-year summary)
Total assets¥4.6bnat 2023-03-31StandaloneAssets
Total assets¥4.8bnat 2022-12-31StandaloneAssets
Total liabilities¥989mat 2023-03-31StandaloneLiabilities
Total liabilities¥1.0bnat 2022-12-31StandaloneLiabilities
Net assets / equity¥3.6bnat 2023-03-31StandaloneNet assets
Net assets / equity¥3.8bnat 2022-12-31StandaloneNet assets
Cash and deposits¥4.3bnat 2023-03-31StandaloneCash and deposits
Cash and deposits¥4.4bnat 2022-12-31StandaloneCash and deposits
EPS (basic)¥-21.562023-01-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-177.672022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
Equity ratio78.5%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio78.3%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued7,803,300at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued7,773,300at 2022-12-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 225
ItemContextValueUnit
Company name in english cover pageFilingDateInstantCyfuse Biomedical K.K
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役 秋枝 静香
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都港区三田三丁目5番27号 住友不動産三田ツインビル西館
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03-6435-1885(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役 CFO 経営管理部長 三條 真弘
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都港区三田三丁目5番27号 住友不動産三田ツインビル西館
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03-6435-1885(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役 CFO 経営管理部長 三條 真弘
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE38156
Fund codeFilingDateInstant-
Security codeFilingDateInstant48920
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社サイフューズ
Filer name in englishFilingDateInstantCyfuse Biomedical K.K.
Fund name in japaneseFilingDateInstant-
Fund name in englishFilingDateInstant-
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant-
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Current fiscal year start dateFilingDateInstant2023-01-01
Current period end dateFilingDateInstant2023-03-31
Type of current periodFilingDateInstantQ1
Current fiscal year end dateFilingDateInstant2023-12-31
Previous fiscal year start dateFilingDateInstant2022-01-01
Comparative period end dateFilingDateInstant2022-03-31
Previous fiscal year end dateFilingDateInstant2022-12-31
Next fiscal year start dateFilingDateInstant-
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant-
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant-
Report amendment flagFilingDateInstantfalse
Xbrl amendment flagFilingDateInstantfalse
Business results of reporting company (text)FilingDateInstantText · Plus
Description of business (text)FilingDateInstantText · Plus
Business risks (text)FilingDateInstantText · Plus
Management analysis of financial position operating results and cash flows (text)FilingDateInstantText · Plus
Critical contracts for operation (text)FilingDateInstantText · Plus
Total number of shares (text)FilingDateInstantText · Plus
Issued shares total number of shares etc (text)FilingDateInstantText · Plus
Class issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)普通株式
Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registeredFilingDateInstant_OrdinaryShareMember
Original text (Japanese)東京証券取引所グロース市場
Description issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)単元株式数は100株であります。
Details of employee share option program (text)FilingDateInstantText · Plus
Other information on share acquisition rights (text)FilingDateInstantText · Plus
Exercises etc of moving strike convertible bonds etc (text)FilingDateInstantText · Plus
Changes in number of issued shares stated capital etc (text)FilingDateInstantText · Plus
Major shareholders (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 9 of 9 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass